| Trial ID: | L5794 |
| Source ID: | NCT00006185
|
| Associated Drug: |
Avandia Administration For 6-12 Weeks
|
| Title: |
Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
HIV Infections|Lipodystrophy|Insulin Resistance
|
| Interventions: |
DRUG: Avandia administration for 6-12 weeks
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
1999-09
|
| Completion Date: |
2003-08
|
| Results First Posted: |
|
| Last Update Posted: |
2010-03-02
|
| Locations: |
University Hospital at Stony Brook New York, Stony Brook, New York, 11794, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00006185
|
